EMA
approval
· 2026-08-07
EMA Authorised: Spedra (avanafil) — Phoenix Labs Unlimited Company
Summary
The EMA Authorised Spedra (avanafil) for erectile dysfunction, listing Phoenix Labs Unlimited Company as the MAH with an authorised status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Phoenix Labs Unlimited Company. Decision date: 05/08/2026